India to Finland: Allopurinol Export Trade Route
India has recorded 38 verified shipments of Allopurinol exported to Finland, representing a combined trade value of $4.0M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $106.0K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 93% of total export value with 28 shipments worth $3.7M USD. On the buying side, NA is the largest importer in Finland with $3.0M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Finland Allopurinol corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $4.0M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $106.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #19 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in Finland include NA, ORION CORPORATION, TO THE ORDER and 3 others. NA is the single largest importer with 16 shipments valued at $3.0M USD.
